Toronto Dominion Bank Sells 4,352 Shares of Danaher Co. (NYSE:DHR)
Toronto Dominion Bank lowered its position in shares of Danaher Co. (NYSE:DHR) by 0.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 468,533 shares of the conglomerate’s stock after selling 4,352 shares during the period. Toronto Dominion Bank owned about 0.07% of Danaher worth $66,944,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in DHR. Next Capital Management LLC acquired a new stake in Danaher in the second quarter worth about $31,000. Litman Gregory Asset Management LLC acquired a new stake in Danaher in the 2nd quarter worth approximately $33,000. Altshuler Shaham Ltd boosted its stake in Danaher by 59.3% in the 2nd quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 89 shares in the last quarter. Lenox Wealth Management Inc. purchased a new stake in Danaher during the 1st quarter worth approximately $40,000. Finally, MRA Associates USA LLC purchased a new stake in Danaher during the 2nd quarter worth approximately $40,000. Hedge funds and other institutional investors own 78.52% of the company’s stock.
NYSE DHR traded up $2.99 on Wednesday, hitting $139.58. 117,856 shares of the company’s stock traded hands, compared to its average volume of 1,809,357. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $145.50. The firm’s 50-day moving average price is $140.24 and its two-hundred day moving average price is $134.97. The firm has a market capitalization of $99.97 billion, a PE ratio of 30.90, a P/E/G ratio of 2.52 and a beta of 0.94.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. Danaher’s dividend payout ratio is presently 15.04%.
A number of research analysts have issued reports on the stock. Robert W. Baird raised their price target on shares of Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Royal Bank of Canada set a $134.00 price objective on shares of Danaher and gave the company a “hold” rating in a report on Friday, July 19th. Piper Jaffray Companies upped their target price on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Needham & Company LLC restated a “buy” rating and issued a $155.00 target price (up previously from $142.00) on shares of Danaher in a research note on Friday, July 19th. Finally, Wolfe Research assumed coverage on Danaher in a research note on Thursday, May 30th. They issued an “outperform” rating for the company. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Danaher has a consensus rating of “Buy” and a consensus target price of $143.54.
In other Danaher news, insider Thomas Patrick Joyce, Jr. sold 70,544 shares of the firm’s stock in a transaction on Friday, July 19th. The stock was sold at an average price of $141.77, for a total value of $10,001,022.88. Following the transaction, the insider now owns 271,023 shares in the company, valued at approximately $38,422,930.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Daniel L. Comas sold 68,379 shares of the firm’s stock in a transaction on Friday, July 19th. The shares were sold at an average price of $142.05, for a total value of $9,713,236.95. Following the completion of the transaction, the executive vice president now owns 187,474 shares in the company, valued at approximately $26,630,681.70. The disclosure for this sale can be found here. Over the last quarter, insiders sold 177,202 shares of company stock worth $25,175,829. 11.40% of the stock is currently owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Story: What is Put Option Volume?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.